These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 85952

  • 1. HLA-B27, Klebsiella, and ankylosing spondylitis.
    Geczy AF, Yap J.
    Lancet; 1979 Mar 31; 1(8118):719-20. PubMed ID: 85952
    [No Abstract] [Full Text] [Related]

  • 2. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
    Georgopoulos K, Dick WC, Goodacre JA, Pain RH.
    Clin Exp Immunol; 1985 Dec 31; 62(3):662-71. PubMed ID: 3878755
    [Abstract] [Full Text] [Related]

  • 3. Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera.
    Welsh J, Avakian H, Cowling P, Ebringer A, Wooley P, Panayi G, Ebringer R.
    Br J Exp Pathol; 1980 Feb 31; 61(1):85-91. PubMed ID: 6769456
    [Abstract] [Full Text] [Related]

  • 4. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis.
    Geczy AF, Seager K, Bashir HV, de Vere-Tyndall A, Edmonds J.
    J Clin Lab Immunol; 1980 Jan 31; 3(1):23-8. PubMed ID: 7381924
    [Abstract] [Full Text] [Related]

  • 5. The enigma of the Klebsiella connection and ankylosing spondylitis: a commentary.
    Prendergast JK, Sullivan JS, Geczy AF, Upfold LI, Edmonds JP, Bashir HV.
    Hum Immunol; 1984 Mar 31; 9(3):131-6. PubMed ID: 6365855
    [No Abstract] [Full Text] [Related]

  • 6. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
    Sullivan JS, Geczy AF.
    Arthritis Rheum; 1987 Apr 31; 30(4):439-42. PubMed ID: 2437933
    [Abstract] [Full Text] [Related]

  • 7. Blind confirmation of Geczy factor in ankylosing spondylitis.
    van Rood JJ, van Leeuwen A, Ivanyi P, Cats A, Breur-Vriesendorp BS, Dekker-Saeys AJ, Kijlstra A, van Kregten E.
    Lancet; 1985 Oct 26; 2(8461):943-4. PubMed ID: 2865436
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ankylosing spondylitis, HLA-B27, and Klebsiella: a study of lymphocyte reactivity of anti-Klebsiella sera.
    Singh B, Milton JD, Woodrow JC.
    Ann Rheum Dis; 1986 Mar 26; 45(3):190-7. PubMed ID: 3485408
    [Abstract] [Full Text] [Related]

  • 10. Ankylosing spondylitis, HLA-B27 and Klebsiella. II. Cross-reactivity studies with human tissue typing sera.
    Avakian H, Welsh J, Ebringer A, Entwistle CC.
    Br J Exp Pathol; 1980 Feb 26; 61(1):92-6. PubMed ID: 6990955
    [Abstract] [Full Text] [Related]

  • 11. The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and HLA B27 in ankylosing spondylitis patients and healthy controls.
    Baines M, Ebringer A, Avakian H, Samuel D, James DC.
    Scand J Rheumatol; 1990 Feb 26; 19(5):341-9. PubMed ID: 1699267
    [Abstract] [Full Text] [Related]

  • 12. Ankylosing spondylitis and Klebsiella--the debate continues.
    Ebringer A.
    J Rheumatol; 1991 Mar 26; 18(3):312-3. PubMed ID: 1856800
    [No Abstract] [Full Text] [Related]

  • 13. Effect of klebsiella capsular antisera on lymphocytes from patients with ankylosing spondylitis.
    Shinebaum R, Cooke EM, Siegerstetter J, Wright V.
    J Med Microbiol; 1981 Nov 26; 14(4):451-6. PubMed ID: 7310846
    [Abstract] [Full Text] [Related]

  • 14. Spondyloarthritis, uveitis, HLA-B27 and Klebsiella.
    Ebringer A, Baines M, Ptaszynska T.
    Immunol Rev; 1985 Aug 26; 86():101-16. PubMed ID: 2412951
    [Abstract] [Full Text] [Related]

  • 15. The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis.
    Ebringer A.
    Br J Rheumatol; 1983 Nov 26; 22(4 Suppl 2):53-66. PubMed ID: 6418259
    [Abstract] [Full Text] [Related]

  • 16. HLA antigens as carrier molecules.
    van Rood JJ.
    Hum Immunol; 1986 Nov 26; 17(3):246-9. PubMed ID: 3491813
    [No Abstract] [Full Text] [Related]

  • 17. Cross-reactivity of anti-Klebsiella K43 BTS 1 serum and lymphocytes of patients with ankylosing spondylitis: antipodean curiosity?
    Geczy AF, Prendergast JK, McGuigan LE, Upfold LI, Sullivan JS.
    Lancet; 1985 May 18; 1(8438):1169. PubMed ID: 2860379
    [No Abstract] [Full Text] [Related]

  • 18. Ankylosing spondylitis, HLA-B27, and klebsiella: cross reactivity and antibody studies.
    Ebringer A, Ghuloom M.
    Ann Rheum Dis; 1986 Aug 18; 45(8):703-4. PubMed ID: 3488716
    [No Abstract] [Full Text] [Related]

  • 19. Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population.
    Archer JR, Stubbs MM, Currey HL, Geczy AF.
    Lancet; 1985 Feb 09; 1(8424):344-5. PubMed ID: 2857398
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical studies on a factor isolated from Klebsiella K43-BTS1 that cross-reacts with cells from HLA-B27 positive patients with ankylosing spondylitis.
    Upfold LI, Sullivan JS, Geczy AF.
    Hum Immunol; 1986 Nov 09; 17(3):224-38. PubMed ID: 3539895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.